- Potential benefitMay increase beneficiary access to diabetic shoes by allowing more clinicians to certify eligibility.
- Potential benefitCould reduce wait times for documentation and speed provision of therapeutic footwear.
- Potential benefitLikely reduces administrative burden on physicians and improves care coordination among provider teams.
Promoting Access to Diabetic Shoes Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The bill amends section 1861(s)(12) of the Social Security Act to allow nurse practitioners and physician assistants to satisfy Medicare documentation requirements for coverage of therapeutic shoes and inserts for people with diabetes. It inserts “nurse practitioner, or physician assistant” alongside “physician” in the relevant statutory subsections.
Liberal emphasizes access and equity benefits
Narrow, technical Medicare amendment with likely bipartisan appeal; committee prioritization is main hurdle.
The bill amends section 1861(s)(12) of the Social Security Act to allow nurse practitioners and physician assistants to satisfy Medicare documentation requirements for coverage of therapeutic shoes and inserts for people with diabetes.
It inserts “nurse practitioner, or physician assistant” alongside “physician” in the relevant statutory subsections.
The change is limited to who may provide the required documentation for Medicare coverage of certain diabetic footwear.
Content is narrow and noncontroversial, increasing chance, but many isolated statutory tweaks require carriage in larger health/Medicare vehicles.
How solid the drafting looks.
Liberal emphasizes access and equity benefits
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenCould increase Medicare expenditures from higher utilization of covered shoes and related claims.
- Potential burdenMay introduce variability in documentation quality and clinical judgments across provider types.
- Potential burdenPossible increased risk of improper billing or fraud if oversight is not strengthened.
Why the argument around this bill splits.
Liberal emphasizes access and equity benefits
Likely strongly supportive.
The provision removes an access barrier for Medicare beneficiaries, especially in underserved or rural areas, and aligns with expanding qualified clinicians' roles.
Advocates would see it as a practical step to increase preventive care for diabetics.
Generally supportive but pragmatic.
The change simplifies access and could reduce administrative burden, but would want a nonpartisan estimate of fiscal impact and clear CMS implementation guidance.
Views it as low-risk if accompanied by oversight.
Cautious, with mixed reactions.
Some conservatives will welcome reduced barriers and expanded use of NPs/PAs; others will worry about expanding non-physician authority, potential program cost increases, and federal program creep.
Support depends on assurances about costs and accountability.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrow and noncontroversial, increasing chance, but many isolated statutory tweaks require carriage in larger health/Medicare vehicles.
- Absent cost estimate or CBO score
- Whether CMS regulation updates are needed
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes access and equity benefits
Content is narrow and noncontroversial, increasing chance, but many isolated statutory tweaks require carriage in larger health/Medicare ve…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Promoting Access to Diabetic Shoes Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.